Literature DB >> 1106760

Cavernous haemangioma of the retina and optic disc. A report of three cases and a review of the literature.

R A Lewis, M H Cohen, G N Wise.   

Abstract

We report characteristics of three cases of cavernous haemangioma of the retina, bringing to 37 the number now reported in the available literature. This rare, benign, congenital malformation is non-progressive, usually unilateral, somewhat more frequent in women, and rarely a source of intraocular haemorrhage. The fluorescein angiographic features include a normal arterial and venous supply, extraordinarily slowed venous drainage, no arterio-venous shunting, no disturbances of vascular permeability, and no secondary retinal exudation. Almost always, isolated clusters of vascular globules with plasma/erythrocyte sedimentation surround the main body of the malformation. These findings differentiate the anomaly from other retinal vascular diseases. Therapeutic intervention is seldom necessary.

Entities:  

Mesh:

Year:  1975        PMID: 1106760      PMCID: PMC1017387          DOI: 10.1136/bjo.59.8.422

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  11 in total

1.  Hemangioma of the optic disc.

Authors:  E F WALLNER; L T MOORMAN
Journal:  AMA Arch Ophthalmol       Date:  1955-01

2.  [Cavernous angioma of the retina].

Authors:  H J PIPER
Journal:  Ophthalmologica       Date:  1954-08       Impact factor: 3.250

3.  Retinal neovascularization, collaterals, and vascular shunts.

Authors:  P Henkind; G N Wise
Journal:  Br J Ophthalmol       Date:  1974-04       Impact factor: 4.638

4.  Arteriovenous communications of the retina.

Authors:  D B Archer; A Deutman; J T Ernest; A E Krill
Journal:  Am J Ophthalmol       Date:  1973-02       Impact factor: 5.258

5.  [Retinal angioma and toxoplasmosis].

Authors:  C A Stucchi; G Bianchi; F Cometta; R Faggioni
Journal:  Ophthalmologica       Date:  1972       Impact factor: 3.250

6.  Retinal angiomatosis. Atypical cases of retinal angiomatosis and telangiectases.

Authors:  R Witmer; F Verrey; P Speiser
Journal:  Bibl Ophthalmol       Date:  1968

7.  Cavernous hemangioma of the retina. A neuro-oculo-cutaneous syndrome.

Authors:  J D Gass
Journal:  Am J Ophthalmol       Date:  1971-04       Impact factor: 5.258

8.  Ocular and nervous system involvement in angioma serpiginosum.

Authors:  P C Gautier-Smith; M D Sanders; K V Sanderson
Journal:  Br J Ophthalmol       Date:  1971-07       Impact factor: 4.638

9.  Fluorescein angiography in von Hippel-Lindau disease.

Authors:  W M Haining; P H Zweifach
Journal:  Arch Ophthalmol       Date:  1967-10

10.  Retinal telangiectasia associated with hypogammaglobulinemia.

Authors:  M Frenkel; H P Russe
Journal:  Am J Ophthalmol       Date:  1967-02       Impact factor: 5.258

View more
  6 in total

1.  Haemorrhage of a cavernous haemangioma of the optic disc in pregnancy.

Authors:  José I Vela; Marta Garcia-Vilaró; José A Buil
Journal:  BMJ Case Rep       Date:  2010-12-29

2.  Ocular melanocytosis and cavernous haemangioma of the optic disc.

Authors:  L Zografos; M Gonvers
Journal:  Br J Ophthalmol       Date:  1994-01       Impact factor: 4.638

3.  Acquired arterial macroaneurysms of the retina.

Authors:  R A Lewis; E W Norton; J D Gass
Journal:  Br J Ophthalmol       Date:  1976-01       Impact factor: 4.638

4.  Classification and management of hereditary retinal angiomas.

Authors:  J J Augsburger; J A Shields; R E Goldberg
Journal:  Int Ophthalmol       Date:  1981-08       Impact factor: 2.031

5.  Therapeutic surprise! Photodynamic therapy for cavernous haemangioma of the disc.

Authors:  Mahesh P Shanmugam; Rajesh Ramanjulu; Shyamal Dwivedi; Aditya Barigali; Ajith Havanje
Journal:  Indian J Ophthalmol       Date:  2017-08       Impact factor: 1.848

6.  Case report: Vitreous hemorrhage as the presenting sign of retinal cavernous hemangioma in a newborn.

Authors:  Benjamin J Fowler; Lilla Simon; Nathan L Scott; Catherin I Negron; Audina M Berrocal
Journal:  Am J Ophthalmol Case Rep       Date:  2021-07-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.